Zevra Therapeutics
Price & Volume
Stats
See more52W Range | $6.19-$13.16 |
Market Cap | $471.7M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $84.3M |
Revenue Growth (YoY) | 605.4% |
Gross Profit (12 Mos) | $68M |
Diluted EPS | $0.47 |
News
See moreYahoo Finance • last month
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD
Yahoo Finance • 2 months ago
Zevra Therapeutics, Inc. Announces CFO Transition
Yahoo Finance • 2 months ago
Zevra Reports Third Quarter 2025 Financial Results and Corporate Update
About
CEO | Mr. Neil F. McFarlane |
Address | 1180 Celebration Boulevard, Celebration, FL, United States, 34747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
